AbstractT he effect of copper (Cu) depletion on the growth of tumors was investigated in a rat brain tumor model. 9L gliosarcoma cells were injected subcutaneously in 5-week-old male Fischer-344 rats. The control group (n = 18) received a normal diet throughout the experiment and the depletion group (n = 18) received a Cu-deficient diet starting 3 weeks prior to tumor implantation, and 2 mg of D penicillamine orally, once daily, on the 3 days before and after implantation.
Introduction

Copper
(Cu), a trace element essential for homeostasis and important in cell growth, is ac cumulated in the serum and tumor tissue of patients with various cancers and is correlated with the tumor malignancy and patient prognosis!)
We previously reported abnormally elevated levels of Cu in malig nant gliomas.12 Cu is a cofactor of angiogenesis and several molecules that bind Cu are potentially angiogenic.5°6) Cu has a high affinity with heparin and fibroblast growth factor9) which are both capable of stimulating tumor angiogenesis." ) Angiogenesis is a key factor of tumor growth.4) The inhibition of tumor angiogenesis may control tumor growth by preventing the exponential vascular growth phase. The mechanism of Cu-bound molecular stimulation of cell growth and the potential inhibition of the bioactivity of tumor cells must involve the affinity and transfer kinetics between Cu and the molecule.
A rat brain glioma model was previously used to show the effect of reduced Cu serum concentra tion caused by Cu depletion on angiogenesis.') This study determined the effects on tissue Cu con centration and inhibition of tumor growth of Cu depletion caused by a Cu-free diet and D-penicil lamine treatment in the rat brain glioma model.
Materials
and Methods 9L gliosarcoma cells were cultured in incubation medium (RPMI-1640 supplemented with 10 mg/ml of gentacin) and maintained in a humidified in cubator at 37 C. The trypsinized and lifted cells were resuspended in phosphate buffered saline at a concentration of 106 cells/ml. Thirty-six male 5 week-old Fischer-344 rats, weighing 240-250g, were anesthetized with ether. Cell suspension con taining 105 cells (100,ul) was slowly injected subcu taneously through a 26-gauge needle. We divided the rats into two groups by the methods of Brem et al.') as follows.The control group (n = 18) was fed normal diet through the experiment. The depletion group (n = 18) was fed a Cu-deficient diet starting 3 weeks prior to the tumor cell implantation and also received 2 mg of D-penicillamine per day oral ly for 6 days, beginning 3 days before implanta tion.
Six animals from each group were killed with ether 1, 2, and 3 weeks after the implantation. The brain and tumor tissue were removed. The mass of the tumor tissue was determined. Tissue Cu levels were measured using a Hitachi 170-30 atomic absorption spectrophotometer (Tokyo). The statistical signifi cance of differences in values was established using the Student's t-test. All the subcutaneous tumors were well marginated from the surrounding subcutaneous tissue, and were easily removed. The tumor weight increased rapidly in the control group but much more slowly in the depletion group (Fig. 1) . The tumor tissue in the de pletion group weighed significantly less than that in the control group at each week (1 wk, p < 0.05; 2 wks, p < 0.01; 3 wks, p < 0.001).
Three weeks after implantation, the animals in both groups had developed normally. The animal weights of both groups showed no significant difference.
No symptoms such as behavioral disorders or paresis were observed.
Discussion
Our study showed that 9L gliosarcoma tissue con tains a significantly higher Cu concentration than normal rat brain tissue. Such abnormal elevation of Cu level has been found in several malignant tissues." Brem et mainly focused on the effect of the serum concentra tion of Cu ion on angiogenesis using Cu depletion and D-penicillamine treatment in experimental animals,
showing that such therapy diminished nuclear staining with Cu. Our study in the same rat model found that Cu depletion and D-penicillamine treatment achieved significant inhibition of tumor cell growth. Our results also indicated that the treat ment reduced the concentration of Cu ion in glioma tissue.
D-penicillamine is used to treat patients with rheumatoid arthritis, as well as Wilson's disease or congenital Cu storage disease. D-penicillamine has a superoxide-dismutase-like action.") Production of H202 by D-penicillamine in the presence of Cu ion was observed in a cell-free system and inhibited en dothelial cell proliferation.
This inhibition was synergistically enhanced by the presence of Cu ion in a dose-dependent fashion.') Endothelial cell prolifera tion and collagenase are closely concerned with angiogenesis.
Such superoxide-dismutase-like and angiosuppressive actions may be another factor in the observed inhibition of tumor growth."
Severe Cu deficiency can result in normocytic or megaloblastic anemia, neutropenia, and osteoporo sis.') No specific neurological abnormalities have been described. We found that the tissue concentra tions of Cu were significantly depleted in tumor tissue, but no statistical difference was seen in the brain between control and treated animals. These results suggest that Cu-depletion therapy affected the subcutaneous tumor and might not have an ef fect on tumor implanted in the brain. Mechanisms such as the blood-brain barrier may prevent central nervous system Cu depletion, but the central ner vous system may tolerate Cu deficiency for a lim ited period allowing clinical usage. Brem et al. ') found that selective Cu depletion may occur in tu mor implanted in the brain, but with increased peritumoral vascular permeability and brain water content. Methods to achieve Cu depletion of tumor implanted in the brain should be thoroughly in vestigated.
